Greenwich LifeSciences, Inc. (GLSI)
19.53
-1.48
(-7.04%)
USD |
NASDAQ |
Jan 02, 16:00
19.50
-0.03
(-0.15%)
After-Hours: 17:44
Greenwich LifeSciences Market Cap: 270.58M for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 15.36M |
| AIM ImmunoTech, Inc. | 0.9208M |
| IGC Pharma, Inc. | 26.67M |
| NovaBay Pharmaceuticals, Inc. | 732.75M |
| Protalix Biotherapeutics, Inc. | 140.34M |
Market Cap Related Metrics
| PEG Ratio | -0.1657 |
| Price to Book Value | 123.84 |
| Price | 19.53 |
| Earnings Yield | -7.50% |
| PEGY Ratio | -0.1657 |